Role of Composite Measurable Residual Disease Assessment with PET-CT and flow cytometry in Multiple Myeloma patients undergoing Autologous Transplant
Pre-ASCT cMRD assessment using both PET-CT and bone marrow FCM provides prognostic value in NDMM. This approach is particularly relevant in real-world settings where patients often receive prolonged induction therapy before ASCT.
Authors
- Alka Khadwal (ORCID: https://orcid.org/0000-0002-4360-9348)
- Deepesh Lad (ORCID: https://orcid.org/0000-0003-3754-7774)
- Rudra Narayan Swain (ORCID: https://orcid.org/0009-0000-7703-4696)
- Sarthak Wadhera (ORCID: https://orcid.org/0000-0002-1722-7880)
- Man Updesh Singh Sachdeva (ORCID: https://orcid.org/0000-0002-4406-8299)
- Aditya Jandial (ORCID: https://orcid.org/0000-0002-6426-0309)
- Reena Das (ORCID: https://orcid.org/0000-0002-8938-5423)
- Gaurav Prakash (ORCID: https://orcid.org/0000-0002-1505-8024)
- Charanpreet Singh (ORCID: https://orcid.org/0000-0002-8189-8128)
- Pankaj Malhotra (ORCID: https://orcid.org/0000-0001-5577-6613)
- Arihant Jain (ORCID: https://orcid.org/0000-0001-9495-9789)
- R.K. Basher
- Sreejesh Sreedharuni
Institutions
- Post Graduate Institute of Medical Education and Research (IN)
Publication Details
- Journal
- BLOOD CELL THERAPY / The official journal of APBMT
- Published
- 2025-01-01
- DOI
- https://doi.org/10.31547/bct-2025-002
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00